Dechra Veterinary Products has announced the UK launch of Recicort (triamcinolone acetonide and salicylic acid; POM-V),  indicated for the treatment of otitis externa and for symptomatic treatment of seborrhoeic dermatitis of the auricle.

Dechra says the combination of triamcinolone acetonide and salicylic acid works to provide effective symptomatic treatment, particularly for certain types of otitis externa that are not caused by a bacterial or yeast infection, such as flare ups caused by allergies.

Dechra Brand Manager Carol Morgan said: "Otitis externa is a condition that causes inflammation of the external ear canal and it can have a debilitating effect on cats and dogs.

"Recicort is a moderately potent steroid with an anti-inflammatory and vasoconstrictive action that works by suppressing the inflammatory response and the symptoms of various disorders often associated with itching. It doesn’t contain an antibiotic or antimycotic so it won’t contribute to antimicrobial resistance either.

"This prescription-only treatment is an important addition to our dermatology portfolio for veterinary professionals who are looking for a suite of highly effective and cost effective treatments."

Recicort is available in 20 ml bottles. For more information visit: www.dechra.co.uk 

PS: Whilst you're here, take a moment to see our latest job opportunities for vets.